Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Chubb
Fuji
Dow
Queensland Health
Boehringer Ingelheim
Deloitte
QuintilesIMS

Generated: April 19, 2018

DrugPatentWatch Database Preview

TUSSIONEX PENNKINETIC Drug Profile

« Back to Dashboard

When do Tussionex Pennkinetic patents expire, and when can generic versions of Tussionex Pennkinetic launch?

Tussionex Pennkinetic is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in TUSSIONEX PENNKINETIC is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
Drug patent expirations by year for TUSSIONEX PENNKINETIC
Pharmacology for TUSSIONEX PENNKINETIC
Synonyms for TUSSIONEX PENNKINETIC
131219-97-1
Chlorpheniramine / hydrocodone
Chlorpheniramine Mixture With Hydrocodone
Chlorpheniramine polistirex / Hydrocodone polistirex
Chlorpheniramine polistirex and Hydrocodone polistirex
DTXSID50156960
Hydrocodone conbination product 15 mg/du
Hydrocodone polistirex and chlorpheniramine polistirex
S-T Forte 2
SCHEMBL2522788
Tussicaps
Tussicaps extended-release
Tussionex
Tuzistra XR
Vituz

US Patents and Regulatory Information for TUSSIONEX PENNKINETIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc TUSSIONEX PENNKINETIC chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 019111-001 Dec 31, 1987 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TUSSIONEX PENNKINETIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc TUSSIONEX PENNKINETIC chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 019111-001 Dec 31, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc TUSSIONEX PENNKINETIC chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 019111-001 Dec 31, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
QuintilesIMS
Chubb
Fish and Richardson
Moodys
Julphar
Covington
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.